Medicine and Dentistry
Diagnosis
100%
Cytotechnology
79%
Fine-Needle Aspiration
71%
Neoplasm
61%
Cervical Cancer Screening
61%
Wart Virus
61%
Immunohistochemistry
53%
Methylation
51%
Papillomatosis
45%
Screening
45%
Positron Emission Tomography-Computed Tomography
43%
Thyroid Nodule
38%
Cytopathology
35%
Papillary Thyroid Cancer
34%
Liquid-Based Cytology
33%
Cancer
33%
Scatter Factor Receptor
30%
Cervical Lymph Node Metastasis
30%
Neuroendocrine Carcinoma
30%
Squamous Cell Carcinoma Antigen
30%
Health Care Cost
30%
Thyroid Cancer
30%
Malignant Neoplasm
29%
Patient Referral
28%
Metastatic Carcinoma
26%
Primary Tumor
26%
Cervical Intraepithelial Neoplasia
25%
Lymph Node
24%
Positron Emission Tomography
23%
Human Papillomavirus Type 6
22%
Esophageal Cancer
22%
Prospective Study
22%
Lymph Node Metastasis
22%
Disease
21%
Human Papillomavirus Type 11
21%
Cervical Cancer
20%
Cohort Analysis
19%
Observational Study
19%
Triage
19%
Biopsy
18%
Papanicolaou Stain
18%
Uterine Cervix Cytology
17%
DNA Methylation
17%
Neck
16%
Sensitivity and Specificity
16%
Prevalence
16%
Histopathology
15%
Primary Hyperparathyroidism
15%
Systematic Review
15%
Thyroid Incidentaloma
15%
Keyphrases
Cervical Cancer Screening
45%
Cervista
30%
High-risk Human Papillomavirus (HR-HPV)
30%
Dutch
20%
Primary Screening
19%
HPV Testing
17%
Self-sampling
16%
Aggressiveness
15%
Antigen Concentration
15%
4DCT
15%
Central Lymph Node
15%
Squamous Cell Carcinoma Antigen
15%
Idylla
15%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
15%
Nodal Metastasis
15%
Fine-needle Aspiration
15%
Cervical Lymph Node Metastasis
15%
Vaginal Lavage
15%
Recurrent Respiratory Papillomatosis
15%
ENSAT
15%
Primary Hyperparathyroidism (pHPT)
15%
ThinPrep Imaging System
15%
ThinPrep
15%
EUS-guided FNA
15%
Urine Cytology
15%
Receptor Targets
15%
Excision Margins
15%
LLETZ
15%
Novel Diagnostics
15%
Population-based
15%
Clinical Validation
15%
STING1
15%
11C-methionine PET
15%
MET Receptor
15%
Liquid-based Cytology
15%
Lymph Node Sampling
15%
Line Scan
15%
CCNA1
15%
Cervista HPV HR
15%
High-risk HPV
15%
Human Papillomavirus Testing
15%
Papillary Thyroid Cancer
15%
Laryngeal Neuroendocrine Carcinoma
15%
HPV11
15%
Methylation Panel
15%
CIN3+
15%
International Guidelines
15%
Human Papillomavirus 11
15%
SSTR2A
15%
Human Papillomavirus 6
15%